Volume 30 Issue 3
Jun.  2021
Turn off MathJax
Article Contents
HU Ying-lian. The Construction of Drug Safety Risk Governance System in China[J]. Journal of University of Science and Technology Beijing ( Social Sciences Edition), 2014, 30(3): 98-102.
Citation: HU Ying-lian. The Construction of Drug Safety Risk Governance System in China[J]. Journal of University of Science and Technology Beijing ( Social Sciences Edition), 2014, 30(3): 98-102.

The Construction of Drug Safety Risk Governance System in China

  • Received Date: 2014-02-23
  • Publish Date: 2021-06-21
  • Fragmentation, diffusion, concealment and diversification compose of modern drug safety risk features. From the perspective of risk governance theory, there exist some defects within drug regulatory system, including single institutional function, decentralized administration, individual risk ignorance and "campaign-style" emergency management. To improve the performance of drug regulation and reconstruct the top design of drug regulatory system, it is necessary to take advantage of this round of administrative reform and the "Drug Administration Law" revision. Policy suggestions of a new paradigm of drug safety risk governance system are followed: innovate drug safety risk analysis framework, establish a high-level drug administration coordinating body, improve local regulatory system, and mobilize the involvement of stakeholders.

     

  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (277) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return